In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
1839 News Items found
Event
Shawn, a Fred’s Team runner
Why They Run: Fred’s Team Runners Take on the 2017 TCS New York City Marathon

Hear from five Fred’s Team members about why they’re running the New York City Marathon in 2017.
Q&A
MSK Integrative Medicine meditation instructor Emily Herzlin
How Meditation Can Help Those Affected by Cancer: At Work with Emily Herzlin

Meet Emily Herzlin, who teaches mindfulness and meditation at Memorial Sloan Kettering.
Finding
A new study suggests that healthcare providers should consider looking for monoclonal gammopathy of undetermined significance (MGUS) in younger African Americans.
Myeloma Precursor Disease Can Start Much Earlier than Expected, Especially in African Americans

New research has found that a precancerous blood condition can linger undetected for more than 20 years.
Announcement
Memorial Sloan Kettering medical oncologist Paul Hamlin
FDA Approves CAR T Cell Therapy for Non-Hodgkin Lymphoma

This is the second regulatory approval of the cell-based immunotherapy for a blood cancer.
In the Lab
Stem cells induced to become cardiomyocytes
Stem Cell Research Probes Why a Breast Cancer Treatment Sometimes Damages the Heart

Investigators are looking at how and why the breast cancer drug trastuzumab sometimes causes long-lasting and potentially serious cardiac side effects.
Q&A
MSK woman
The Benefits of a Metastatic Breast Cancer Support Group: An Interview with a Social Worker

Learn how a support group could help you if you’ve been diagnosed with metastatic breast cancer.
In the Lab
A micrograph image of breast cancer cells.
Research Reveals How Sleeping Cancer Cells Wake Up

MSK investigators are studying how dormant cancer cells can become reactivated after remaining hidden in the body for years.
In the Clinic
Image of DNA helix with sequence in the background
Genetic ‘Scars’ Provide Clues for Tailoring Cancer Treatment

For the first time, scientists have determined the extent of DNA repair deficiencies across cancer types. Learn what it means for patients.
Quiz
MSK medical oncologist Jasmeet Singh
How Much Do You Know about Breast Cancer Screening? Take Our Quiz

Take a short quiz to test your knowledge of breast cancer screening.
Memorial Sloan Kettering Is Designated as a Qualified Provider-Led Entity under the Protecting Access to Medicare Act

Memorial Sloan Kettering Cancer Center (MSK) is now recognized as the first dedicated cancer center in the United States to be designated as a qualified provider-led entity (QPLE) under Medicare’s program for appropriate use criteria (AUC). This designation allows MSK to establish best practice standards for the use of CT scans, MRI, and nuclear medicine imaging from initial screening and diagnosis through all stages of cancer care, including survivorship.